1.Czech MP: Insulin action and resistance in obesity and type 2 diabetes. Nature medicine 2017, 23(7):804–814.
2.Shamsaldeen YA, Mackenzie LS, Lione LA, Benham CD: Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies. Current drug metabolism 2016, 17(4):359–367.
3.Matafome P, Rodrigues T, Sena C, Seica R: Methylglyoxal in Metabolic Disorders: Facts, Myths, and Promises. Medicinal research reviews 2017, 37(2):368–403.
4.Nigro C, Raciti GA, Leone A, Fleming TH, Longo M, Prevenzano I, Fiory F, Mirra P, D’Esposito V, Ulianich L et al: Methylglyoxal impairs endothelial insulin sensitivity both in vitro and in vivo. Diabetologia 2014, 57(7):1485–1494.
5.Hanssen NMJ, Scheijen J, Jorsal A, Parving HH, Tarnow L, Rossing P, Stehouwer CDA, Schalkwijk CG: Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study. Diabetes 2017, 66(8):2278–2283.
6.Nigro C, Leone A, Raciti GA, Longo M, Mirra P, Formisano P, Beguinot F, Miele C: Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage. International journal of molecular sciences 2017, 18(1).
7.Wang XJ, Ma SB, Liu ZF, Li H, Gao WY: Elevated levels of alpha-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy. Journal of chromatography B, Analytical technologies in the biomedical and life sciences 2019, 1106–1107:19–25.
8.Kim J, Lee YM, Kim CS, Sohn E, Jo K, Shin SD, Kim JS: Ethyl pyruvate prevents methyglyoxal-induced retinal vascular injury in rats. Journal of diabetes research 2013, 2013:460820.
9.Maessen DE, Stehouwer CD, Schalkwijk CG: The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clinical science (London, England: 1979) 2015, 128(12):839–861.
10.Zendjabil M, Favard S, Tse C, Abbou O, Hainque B: [The microRNAs as biomarkers: What prospects?]. Comptes rendus biologies 2017, 340(2):114–131.
11.Tiwari J, Gupta G, de Jesus Andreoli Pinto T, Sharma R, Pabreja K, Matta Y, Arora N, Mishra A, Sharma R, Dua K: Role of microRNAs (miRNAs) in the pathophysiology of diabetes mellitus. Panminerva medica 2018, 60(1):25–28.
12.Li X: MiR–375, a microRNA related to diabetes. Gene 2014, 533(1):1–4.
13.Zhang Y, Yu M, Dai M, Chen C, Tang Q, Jing W, Wang H, Tian W: miR–450a–5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP2. Journal of cell science 2017, 130(6):1158–1168.
14.Mirhashemi F, Scherneck S, Kluth O, Kaiser D, Vogel H, Kluge R, Schurmann A, Neschen S, Joost HG: Diet dependence of diabetes in the New Zealand Obese (NZO) mouse: total fat, but not fat quality or sucrose accelerates and aggravates diabetes. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2011, 119(3):167–171.
15.Rao X, Huang X, Zhou Z, Lin X: An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostatistics, bioinformatics and biomathematics 2013, 3(3):71–85.
16.Voziyan P, Brown KL, Chetyrkin S, Hudson B: Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes. Clinical chemistry and laboratory medicine 2014, 52(1):39–45.
17.Schalkwijk CG: Vascular AGE-ing by methylglyoxal: the past, the present and the future. Diabetologia 2015, 58(8):1715–1719.
18.Liu H, Zhang N, Tian D: MiR–30b is involved in methylglyoxal-induced epithelial-mesenchymal transition of peritoneal mesothelial cells in rats. Cellular & molecular biology letters 2014, 19(2):315–329.
19.Nigro C, Mirra P, Prevenzano I, Leone A, Fiory F, Longo M, Cabaro S, Oriente F, Beguinot F, Miele C: miR–214-Dependent Increase of PHLPP2 Levels Mediates the Impairment of Insulin-Stimulated Akt Activation in Mouse Aortic Endothelial Cells Exposed to Methylglyoxal. International journal of molecular sciences 2018, 19(2).
20.Li SS, Wu Y, Jin X, Jiang C: The SUR2B subunit of rat vascular KATP channel is targeted by miR–9a–3p induced by prolonged exposure to methylglyoxal. American journal of physiology Cell physiology 2015, 308(2):C139–145.
21.Ying C, Sui-Xin L, Kang-Ling X, Wen-Liang Z, Lei D, Yuan L, Fan Z, Chen Z: MicroRNA–492 reverses high glucose-induced insulin resistance in HUVEC cells through targeting resistin. Molecular and cellular biochemistry 2014, 391(1–2):117–125.
22.Wang X, Peng B, Xu C, Gao Z, Cao Y, Liu Z, Liu T: BDNF-ERK1/2 signaling pathway in ketamine-associated lower urinary tract symptoms. Int Urol Nephrol 2016, 48(9):1387–1393.
23.Jia H, Lei X, Li Y, Zhang J, Qiao Z, Li X, Miao L, Li Y: The effect of miR–450a–5p on the biological behavior of serous ovarian cancer SKOV3 cells. Journal of Modern Oncology 2015.
24.Memon MA, Khan RN, Riaz S, Ain QU, Ahmed M, Kumar N: Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences 2018, 23:110.
25.De Nigris V, Pujadas G, La Sala L, Testa R, Genovese S, Ceriello A: Short-term high glucose exposure impairs insulin signaling in endothelial cells. Cardiovascular diabetology 2015, 14:114.
26.Farah C, Kleindienst A, Bolea G, Meyer G, Gayrard S, Geny B, Obert P, Cazorla O, Tanguy S, Reboul C: Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites. Basic research in cardiology 2013, 108(6):389.
27.Li JB, Wang HY, Yao Y, Sun QF, Liu ZH, Liu SQ, Zhuang JL, Wang YP, Liu HY: Overexpression of microRNA–138 alleviates human coronary artery endothelial cell injury and inflammatory response by inhibiting the PI3K/Akt/eNOS pathway. Journal of cellular and molecular medicine 2017, 21(8):1482–1491.
28.Wang L, Hu XH, Huang ZX, Nie Q, Chen ZG, Xiang JW, Qi RL, Yang TH, Xiao Y, Qing WJ et al: Regulation of CREB Functions by Phosphorylation and Sumoylation in Nervous and Visual Systems. Current molecular medicine 2017, 16(10):885–892.
29.de Jesus DS, DeVallance E, Li Y, Falabella M, Guimaraes D, Shiva S, Kaufman BA, Gladwin MT, Pagano PJ: Nox1/Ref–1-mediated activation of CREB promotes Gremlin1-driven endothelial cell proliferation and migration. Redox biology 2019, 22:101138.
30.Hogan MF, Ravnskjaer K, Matsumura S, Huising MO, Hull RL, Kahn SE, Montminy M: Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2. The Journal of biological chemistry 2015, 290(43):25997–26006.
31.Niwano K, Arai M, Koitabashi N, Hara S, Watanabe A, Sekiguchi K, Tanaka T, Iso T, Kurabayashi M: Competitive binding of CREB and ATF2 to cAMP/ATF responsive element regulates eNOS gene expression in endothelial cells. Arteriosclerosis, thrombosis, and vascular biology 2006, 26(5):1036–1042.